A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice NEILVASAN, a ROMANYELENSKY, b KAIWANG, b STACYMOULDER, c HANNAHDZIMITROWICZ, a RONIAVRITSCHER, c BALIANGWANG, c YUNWU, c